This month the Centers for Medicare and Medicaid Services (CMS) issued final regulations for the Medicare Advantage and prescription drug benefit (Part D) programs. The proposed new requirements largely aim to improve the integrity and efficiency of Medicare Part C and Part D, the prescription drug program. CMS projects that the rule will save an estimated $1.615 billion over the next ten years 2015-2024.
